Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
None
Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis

in different ways. It is therefore important to study the evolution of markers according to the different treatments used and secondarily to compare them with each other. Tinzaparin is used in the

  • 0 views
  • 13 Feb, 2021
  • 1 location
None
Efficacy Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care Patients

This study evaluates the pharmacokinetics of tinzaparin during renal replacement therapy (RRT). 60 patients with clinical indication for pharmacological thromboprophylaxis

urine output
renal replacement therapy
critical illness
renal replacement
replacement therapy
  • 2 views
  • 27 Jan, 2021
  • 1 location
None
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

pulmonary embolism) in Queen Mary Hospital. Tinzaparin 175 iu/kg daily will be started after the diagnosis of VTE is confirmed (duplex Doppler ultrasonography for deep vein thrombosis, and computed

pulmonary embolism
venous thrombosis
deep vein thrombosis
anticoagulation therapy
embolism
  • 32 views
  • 22 Jan, 2021
  • 1 location
None
Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.

for thromboprophylaxis with low molecular weight heparin (tinzaparin). In addition to symptomatic patients with multiple myeloma the study aims to investigate VTE risk in all plasma cell

tinzaparin
smoldering myeloma
heparin
thrombophilia
  • 19 views
  • 11 May, 2021
  • 1 location
None
Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients

The primary objective of this study is to evaluate the current management approach with "intermediate" or "therapeutic" doses of tinzaparin for thromboprophylaxis in hospitalized patients, non

  • 0 views
  • 17 Sep, 2021
  • 7 locations
None
Pharmacogenomics of Heparin-Induced Thrombocytopenia

The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin. Heparin is commonly used to prevent blood clots and the investigators may be able to identify genomic markers which can be used to prevent heparin …

  • 14 views
  • 04 May, 2021
  • 1 location